@entity43 ( @entity43 ) is a rare and potentially life-threatening complication of @entity249 treatment occurring during either the luteal phase or early pregnancy. An increasing number of @entity1031 complications associated with the increased use of assisted reproductive techniques have been reported in the literature. Identification of the risk factors is crucial for prevention of @entity1031 in @entity43 @entity1 . Alterations in the hemostatic system cause @entity49 in @entity1 affected by severe @entity43 . Coexistence of inherited hypercoagulable conditions increases the risk of @entity1031 . The role of clinical parameters that can help predict development of @entity715 is controversial. @entity1 with a personal or family history of @entity715 undergoing @entity249 treatment should be considered for @entity49 screening, while routine examination of inherited thrombophilic mutations is not indicated in @entity249 patients. Antithrombotic primary prevention is not indicated in healthy @entity1 undergoing assisted reproductive procedures or in @entity1 with @entity49 . Anticoagulant therapy is indicted if there is clinical evidence of @entity715 or laboratory evidence of @entity49 . In this review, the risks of @entity49 in the @entity43 are discussed.

THE RISK OF XXXX .

@entity43 :: ('MESH:D010051', 'Disease') :: ['Ovarian hyperstimulation syndrome', 'OHSS'] @entity1 :: ('9606', 'Species') :: ['women', 'Patients', 'patients'] @entity249 :: ('MESH:D007246', 'Disease') :: ['infertility', 'infertile'] @entity49 :: ('MESH:D019851', 'Disease') :: ['thrombophilia', 'hypercoagulability'] @entity1031 :: ('MESH:D013923', 'Disease') :: ['thromboembolism', 'thromboembolic', 'thromboembolic events'] @entity715 :: ('MESH:D013927', 'Disease') :: ['thrombosis']
@entity43 :: (MESH:D010051,Disease) :: ['HYPERCOAGULABILITY IN OVARIAN HYPERSTIMULATION SYNDROME']
